查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1631548

子宫肌瘤治疗设备市场规模、份额、趋势分析报告：按技术、治疗模式、地区和细分市场进行预测，2025-2030 年

Uterine Fibroids Treatment Devices Market Size, Share & Trends Analysis Report By Technology (Surgical Techniques, Laparoscopic Techniques), By Mode Of Treatment, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10个工作天内

价格

子宫肌瘤治疗设备市场的成长与趋势：

根据Grand View Research, Inc.的最新报告，全球子宫肌瘤治疗设备市场预计到2030年将达到121亿美元，预计2025年至2030年期间的复合年增长率为9.4%。

子宫肌瘤患者数量的增加以及对子宫肌瘤诊断和治疗相关认识的不断提高正在推动市场的发展。

用于治疗子宫肌瘤（UF）的微创和非侵入性手术由于相关风险的降低而越来越受欢迎。小切口可减轻术后疼痛并促进快速恢復，因此此类手术的采用率很高，并激发了该领域研究和开发的成长。许多主要企业正在投入研发，推出创新的微创和非侵入性手术器材。

此外，预计在预测期内，多项宣传宣传活动、新产品发布以及市场参与企业采用的新技术将推动市场成长。例如，像 Merit Medical 这样的公司不仅致力于传播有关子宫肌瘤的认识，还致力于教育人们了解安全有效的手术替代方案。他们还提供 Ask4UFE 患者教育计划，其中包括资讯图表、小册子、月度报导和时事通讯，基于子宫肌瘤和子宫肌瘤栓塞 (UFE) 的益处。

子宫肌瘤治疗设备市场报告重点：

  • 由于女性子宫肌瘤盛行率不断上升，导致需要有效的手术干预，因此手术技术部门在 2024 年占据了市场主导地位，收益占有率为 34.0%。
  • 预测期内，消融技术部门预计以最高的复合年增长率成长 10.4%。
  • 由于侵入性治疗在治疗严重子宫肌瘤方面已得到证实有效，2024 年侵入性治疗领域占据了市场主导地位，收益占有率最大。
  • 2024 年北美子宫肌瘤治疗设备市场占据全球市场主导地位，收益占有率为 48.2%。

目录

第一章调查方法与范围

第 2 章执行摘要

第 3 章子宫肌瘤治疗设备市场变数、趋势与范围

  • 市场展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 商业环境分析
    • 产业分析-波特五力分析
    • PESTLE分析

第 4 章子宫肌瘤治疗设备市场：技术业务分析

  • 2024 年及 2030 年技术市场占有率
  • 技术细分仪表板
  • 2018 - 2030 年市场规模、预测与趋势分析（按技术分类）
  • 手术技术
  • 腹腔镜技术
  • 消融技术
  • 栓塞

第五章子宫肌瘤治疗设备市场：治疗模式商业分析

  • 治疗模式市场占有率，2024 年和 2030 年
  • 治疗模式细分仪表板
  • 2018 年至 2030 年按治疗模式分類的市场规模、预测与趋势分析
  • 侵入性治疗
  • 微创治疗
  • 非侵入性治疗

第六章子宫肌瘤治疗设备市场：按地区估计和趋势分析

  • 2024 年及 2030 年区域市场占有率分析
  • 区域市场仪表板
  • 2018 年至 2030 年市场规模及预测趋势分析：
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 挪威
    • 丹麦
    • 瑞典
    • 俄罗斯
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 韩国
    • 澳洲
    • 泰国
  • 拉丁美洲
    • 巴西
    • 阿根廷
    • 哥伦比亚
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第七章 竞争格局

  • 参与者概述
  • 企业市场分析
  • 公司分类
  • 战略地图
  • 公司简介/上市公司
    • Medtronic
    • Stryker
    • Boston Scientific Corporation
    • Insightec.
    • CooperSurgical Inc.
    • Hologic, Inc.
    • Lumenis Be Ltd
    • CONMED Corporation.
    • Gynesonics
    • Merit Medical Systems.
Product Code: GVR-4-68038-820-6

Uterine Fibroids Treatment Devices Market Growth & Trends:

The global uterine fibroids treatment devices market size is estimated to reach USD 12.1 billion by 2030, registering to grow at a CAGR of 9.4% from 2025 to 2030 according to a new report by Grand View Research, Inc. An increasing population of uterine fibroids patients and rising awareness initiatives related to fibroids diagnosis and treatment are driving the market.

Minimally invasive and non-invasive surgeries for the treatment of Uterine Fibroids (UF) are gaining popularity owing to the reduced risk associated with these procedures. Smaller incisions decrease post-operative pain and facilitate speedy recovery, thus leading to high adoption of these procedures and triggering the growth of R&D in this field. Many key players are investing in research and development for the launch of innovative minimally and non-invasive surgical instruments.

Furthermore, several awareness campaigns, new product launches, and incorporation of new technologies by market players are expected to fuel the market growth during the forecast period. For instance, companies such as Merit Medical are dedicated to spreading fibroid awareness as well as promoting a safe and effective alternative to surgery. They also provide Ask4UFE patient educational programs, such as infographics, brochures, monthly articles, and newsletters, based on uterine fibroids and the benefits of uterine fibroid embolization (UFE).

Uterine Fibroids Treatment Devices Market Report Highlights:

  • The surgical techniques segment dominated the market with a revenue share of 34.0% in 2024, attributed to the increasing prevalence of uterine fibroids among women, necessitating effective surgical interventions.
  • The ablation techniques segment is projected to grow at the highest CAGR of 10.4% over the forecast period.
  • The invasive treatment segment dominated the market with the largest revenue share in 2024, attributed to its established efficacy in treating severe uterine fibroids.
  • North America uterine fibroids treatment devices market dominated the global market, with a revenue share of 48.2% in 2024, driven by high healthcare spending and advanced medical infrastructure.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Technology
    • 1.2.2. Mode of Treatment
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources
    • 1.5.4. Primary Research
  • 1.6. Information Analysis
    • 1.6.1. Data Analysis Models
  • 1.7. Market Formulation & Data Visualization
  • 1.8. Model Details
    • 1.8.1. Commodity Flow Analysis
  • 1.9. List of Secondary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Uterine Fibroids Treatment Devices Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Business Environment Analysis
    • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
      • 3.3.1.1. Supplier Power
      • 3.3.1.2. Buyer Power
      • 3.3.1.3. Substitution Threat
      • 3.3.1.4. Threat of New Entrants
      • 3.3.1.5. Competitive Rivalry
    • 3.3.2. PESTLE Analysis

Chapter 4. Uterine Fibroids Treatment Devices Market: Technology Business Analysis

  • 4.1. Technology Market Share, 2024 & 2030
  • 4.2. Technology Segment Dashboard
  • 4.3. Market Size & Forecasts and Trend Analysis, by Technology, 2018 to 2030 (USD Billion)
  • 4.4. Surgical Techniques
    • 4.4.1. Surgical Techniques Market, 2018 - 2030 (USD Billion)
    • 4.4.2. Hysterectomy
      • 4.4.2.1. Hysterectomy Market, 2018 - 2030 (USD Billion)
    • 4.4.3. Myomectomy
      • 4.4.3.1. Myomectomy Market, 2018 - 2030 (USD Billion)
  • 4.5. Laparoscopic Techniques
    • 4.5.1. Laparoscopic Techniques Market, 2018 - 2030 (USD Billion)
    • 4.5.2. Laparoscopic Myotectomy
      • 4.5.2.1. Laparoscopic Myotectomy Market, 2018 - 2030 (USD Billion)
    • 4.5.3. Myolysis
      • 4.5.3.1. Myolysis Market, 2018 - 2030 (USD Billion)
  • 4.6. Ablation Techniques
    • 4.6.1. Ablation Techniques Market, 2018 - 2030 (USD Billion)
    • 4.6.2. Microwave Ablation
      • 4.6.2.1. Microwave Ablation Market, 2018 - 2030 (USD Billion)
    • 4.6.3. Hydrothermal Ablation
      • 4.6.3.1. Hydrothermal Ablation Market, 2018 - 2030 (USD Billion)
    • 4.6.4. Cryoablation
      • 4.6.4.1. Cryoablation, 2018 - 2030 (USD Billion)
    • 4.6.5. Ultrasound Ablation
      • 4.6.5.1. Ultrasound Ablation Market, 2018 - 2030 (USD Billion)
      • 4.6.5.2. High Intensity Focused Ultrasound (HIFU)
        • 4.6.5.2.1. High Intensity Focused Ultrasound (HIFU) Market, 2018 - 2030 (USD Billion)
      • 4.6.5.3. MRI-guided Focused Ultrasound (MRgFUS)
        • 4.6.5.3.1. MRI-guided Focused Ultrasound (MRgFUS) Market, 2018 - 2030 (USD Billion)
  • 4.7. Embolization Techniques
    • 4.7.1. Embolization Techniques Market, 2018 - 2030 (USD Billion)

Chapter 5. Uterine Fibroids Treatment Devices Market: Mode of Treatment Business Analysis

  • 5.1. Mode of Treatment Market Share, 2024 & 2030
  • 5.2. Mode of Treatment Segment Dashboard
  • 5.3. Market Size & Forecasts and Trend Analysis, by Mode of Treatment, 2018 to 2030 (USD Billion)
  • 5.4. Invasive Treatment
    • 5.4.1. Invasive Treatment Market, 2018 - 2030 (USD Billion)
  • 5.5. Minimally Invasive Treatment
    • 5.5.1. Minimally Invasive Treatment Market, 2018 - 2030 (USD Billion)
  • 5.6. Non-invasive Treatment
    • 5.6.1. Non-invasive Treatment Market, 2018 - 2030 (USD Billion)

Chapter 6. Uterine Fibroids Treatment Devices Market: Regional Estimates & Trend Analysis

  • 6.1. Regional Market Share Analysis, 2024 & 2030
  • 6.2. Regional Market Dashboard
  • 6.3. Market Size & Forecasts Trend Analysis, 2018 to 2030:
  • 6.4. North America
    • 6.4.1. North America Uterine Fibroids Treatment Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.4.2. U.S.
      • 6.4.2.1. Key Country Dynamics
      • 6.4.2.2. Regulatory Framework
      • 6.4.2.3. Competitive Insights
      • 6.4.2.4. U.S. Uterine Fibroids Treatment Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.4.3. Canada
      • 6.4.3.1. Key Country Dynamics
      • 6.4.3.2. Regulatory Framework
      • 6.4.3.3. Competitive Insights
      • 6.4.3.4. Canada Uterine Fibroids Treatment Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.4.4. Mexico
      • 6.4.4.1. Key Country Dynamics
      • 6.4.4.2. Regulatory Framework
      • 6.4.4.3. Competitive Insights
      • 6.4.4.4. Canada Uterine Fibroids Treatment Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 6.5. Europe
    • 6.5.1. Europe Uterine Fibroids Treatment Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.5.2. UK
      • 6.5.2.1. Key Country Dynamics
      • 6.5.2.2. Regulatory Framework
      • 6.5.2.3. Competitive Insights
      • 6.5.2.4. UK Uterine Fibroids Treatment Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.5.3. Germany
      • 6.5.3.1. Key Country Dynamics
      • 6.5.3.2. Regulatory Framework
      • 6.5.3.3. Competitive Insights
      • 6.5.3.4. Germany Uterine Fibroids Treatment Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.5.4. France
      • 6.5.4.1. Key Country Dynamics
      • 6.5.4.2. Regulatory Framework
      • 6.5.4.3. Competitive Insights
      • 6.5.4.4. France Uterine Fibroids Treatment Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.5.5. Italy
      • 6.5.5.1. Key Country Dynamics
      • 6.5.5.2. Regulatory Framework
      • 6.5.5.3. Competitive Insights
      • 6.5.5.4. Italy Uterine Fibroids Treatment Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.5.6. Spain
      • 6.5.6.1. Key Country Dynamics
      • 6.5.6.2. Regulatory Framework
      • 6.5.6.3. Competitive Insights
      • 6.5.6.4. Spain Uterine Fibroids Treatment Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.5.7. Norway
      • 6.5.7.1. Key Country Dynamics
      • 6.5.7.2. Regulatory Framework
      • 6.5.7.3. Competitive Insights
      • 6.5.7.4. Norway Uterine Fibroids Treatment Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.5.8. Denmark
      • 6.5.8.1. Key Country Dynamics
      • 6.5.8.2. Regulatory Framework
      • 6.5.8.3. Competitive Insights
      • 6.5.8.4. Denmark Uterine Fibroids Treatment Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.5.9. Sweden
      • 6.5.9.1. Key Country Dynamics
      • 6.5.9.2. Regulatory Framework
      • 6.5.9.3. Competitive Insights
      • 6.5.9.4. Sweden Uterine Fibroids Treatment Devices Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Billion)
    • 6.5.10. Russia
      • 6.5.10.1. Key Country Dynamics
      • 6.5.10.2. Regulatory Framework
      • 6.5.10.3. Competitive Insights
      • 6.5.10.4. Russia Uterine Fibroids Treatment Devices Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Billion)
  • 6.6. Asia Pacific
    • 6.6.1. Asia Pacific Uterine Fibroids Treatment Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.6.2. Japan
      • 6.6.2.1. Key Country Dynamics
      • 6.6.2.2. Regulatory Framework
      • 6.6.2.3. Competitive Insights
      • 6.6.2.4. Japan Uterine Fibroids Treatment Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.6.3. China
      • 6.6.3.1. Key Country Dynamics
      • 6.6.3.2. Regulatory Framework
      • 6.6.3.3. Competitive Insights
      • 6.6.3.4. China Uterine Fibroids Treatment Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.6.4. India
      • 6.6.4.1. Key Country Dynamics
      • 6.6.4.2. Regulatory Framework
      • 6.6.4.3. Competitive Insights
      • 6.6.4.4. India Uterine Fibroids Treatment Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.6.5. South Korea
      • 6.6.5.1. Key Country Dynamics
      • 6.6.5.2. Regulatory Framework
      • 6.6.5.3. Competitive Insights
      • 6.6.5.4. South Korea Uterine Fibroids Treatment Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.6.6. Australia
      • 6.6.6.1. Key Country Dynamics
      • 6.6.6.2. Regulatory Framework
      • 6.6.6.3. Competitive Insights
      • 6.6.6.4. Australia Uterine Fibroids Treatment Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.6.7. Thailand
      • 6.6.7.1. Key Country Dynamics
      • 6.6.7.2. Regulatory Framework
      • 6.6.7.3. Competitive Insights
      • 6.6.7.4. Thailand Uterine Fibroids Treatment Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 6.7. Latin America
    • 6.7.1. Latin America Uterine Fibroids Treatment Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.7.2. Brazil
      • 6.7.2.1. Key Country Dynamics
      • 6.7.2.2. Regulatory Framework
      • 6.7.2.3. Competitive Insights
      • 6.7.2.4. Brazil Uterine Fibroids Treatment Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.7.3. Argentina
      • 6.7.3.1. Key Country Dynamics
      • 6.7.3.2. Regulatory Framework
      • 6.7.3.3. Competitive Insights
      • 6.7.3.4. Argentina Uterine Fibroids Treatment Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.7.4. Colombia
      • 6.7.4.1. Key Country Dynamics
      • 6.7.4.2. Regulatory Framework
      • 6.7.4.3. Competitive Insights
      • 6.7.4.4. Colombia Uterine Fibroids Treatment Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 6.8. MEA
    • 6.8.1. MEA Uterine Fibroids Treatment Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.8.2. South Africa
      • 6.8.2.1. Key Country Dynamics
      • 6.8.2.2. Regulatory Framework
      • 6.8.2.3. Competitive Insights
      • 6.8.2.4. South Africa Uterine Fibroids Treatment Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.8.3. Saudi Arabia
      • 6.8.3.1. Key Country Dynamics
      • 6.8.3.2. Regulatory Framework
      • 6.8.3.3. Competitive Insights
      • 6.8.3.4. Saudi Arabia Uterine Fibroids Treatment Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.8.4. UAE
      • 6.8.4.1. Key Country Dynamics
      • 6.8.4.2. Regulatory Framework
      • 6.8.4.3. Competitive Insights
      • 6.8.4.4. UAE Uterine Fibroids Treatment Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.8.5. Kuwait
      • 6.8.5.1. Key Country Dynamics
      • 6.8.5.2. Regulatory Framework
      • 6.8.5.3. Competitive Insights
      • 6.8.5.4. Kuwait Uterine Fibroids Treatment Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)

Chapter 7. Competitive Landscape

  • 7.1. Participant Overview
  • 7.2. Company Market Position Analysis
  • 7.3. Company Categorization
  • 7.4. Strategy Mapping
  • 7.5. Company Profiles/Listing
    • 7.5.1. Medtronic
      • 7.5.1.1. Overview
      • 7.5.1.2. Financial Performance
      • 7.5.1.3. Technology Benchmarking
      • 7.5.1.4. Strategic Initiatives
    • 7.5.2. Stryker
      • 7.5.2.1. Overview
      • 7.5.2.2. Financial Performance
      • 7.5.2.3. Technology Benchmarking
      • 7.5.2.4. Strategic Initiatives
    • 7.5.3. Boston Scientific Corporation
      • 7.5.3.1. Overview
      • 7.5.3.2. Financial Performance
      • 7.5.3.3. Technology Benchmarking
      • 7.5.3.4. Strategic Initiatives
    • 7.5.4. Insightec.
      • 7.5.4.1. Overview
      • 7.5.4.2. Financial Performance
      • 7.5.4.3. Technology Benchmarking
      • 7.5.4.4. Strategic Initiatives
    • 7.5.5. CooperSurgical Inc.
      • 7.5.5.1. Overview
      • 7.5.5.2. Financial Performance
      • 7.5.5.3. Technology Benchmarking
      • 7.5.5.4. Strategic Initiatives
    • 7.5.6. Hologic, Inc.
      • 7.5.6.1. Overview
      • 7.5.6.2. Financial Performance
      • 7.5.6.3. Technology Benchmarking
      • 7.5.6.4. Strategic Initiatives
    • 7.5.7. Lumenis Be Ltd
      • 7.5.7.1. Overview
      • 7.5.7.2. Financial Performance
      • 7.5.7.3. Technology Benchmarking
      • 7.5.7.4. Strategic Initiatives
    • 7.5.8. CONMED Corporation.
      • 7.5.8.1. Overview
      • 7.5.8.2. Financial Performance
      • 7.5.8.3. Technology Benchmarking
      • 7.5.8.4. Strategic Initiatives
    • 7.5.9. Gynesonics
      • 7.5.9.1. Overview
      • 7.5.9.2. Financial Performance
      • 7.5.9.3. Technology Benchmarking
      • 7.5.9.4. Strategic Initiatives
    • 7.5.10. Merit Medical Systems.
      • 7.5.10.1. Overview
      • 7.5.10.2. Financial Performance
      • 7.5.10.3. Technology Benchmarking
      • 7.5.10.4. Strategic Initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 Global uterine fibroids treatment devices market, by region, 2018 - 2030 (USD Billion)
  • Table 4 Global uterine fibroids treatment devices market, by technology, 2018 - 2030 (USD Billion)
  • Table 5 Global uterine fibroids treatment devices market, by mode of treatment, 2018 - 2030 (USD Billion)
  • Table 6 North America uterine fibroids treatment devices market, by country, 2018 - 2030 (USD Billion)
  • Table 7 North America uterine fibroids treatment devices market, by technology, 2018 - 2030 (USD Billion)
  • Table 8 North America uterine fibroids treatment devices market, by mode of treatment, 2018 - 2030 (USD Billion)
  • Table 9 U.S. uterine fibroids treatment devices market, by technology, 2018 - 2030 (USD Billion)
  • Table 10 U.S. uterine fibroids treatment devices market, by mode of treatment, 2018 - 2030 (USD Billion)
  • Table 11 Canada uterine fibroids treatment devices market, by technology, 2018 - 2030 (USD Billion)
  • Table 12 Canada uterine fibroids treatment devices market, by mode of treatment, 2018 - 2030 (USD Billion)
  • Table 13 Mexico uterine fibroids treatment devices market, by technology, 2018 - 2030 (USD Billion)
  • Table 14 Mexico uterine fibroids treatment devices market, by mode of treatment, 2018 - 2030 (USD Billion)
  • Table 15 Europe uterine fibroids treatment devices market, by country, 2018 - 2030 (USD Billion)
  • Table 16 Europe uterine fibroids treatment devices market, by technology, 2018 - 2030 (USD Billion)
  • Table 17 Europe uterine fibroids treatment devices market, by mode of treatment, 2018 - 2030 (USD Billion)
  • Table 18 UK uterine fibroids treatment devices market, by technology, 2018 - 2030 (USD Billion)
  • Table 19 UK uterine fibroids treatment devices market, by mode of treatment, 2018 - 2030 (USD Billion)
  • Table 20 Germany uterine fibroids treatment devices market, by technology, 2018 - 2030 (USD Billion)
  • Table 21 Germany uterine fibroids treatment devices market, by mode of treatment, 2018 - 2030 (USD Billion)
  • Table 22 France uterine fibroids treatment devices market, by technology, 2018 - 2030 (USD Billion)
  • Table 23 France uterine fibroids treatment devices market, by mode of treatment, 2018 - 2030 (USD Billion)
  • Table 24 Italy uterine fibroids treatment devices market, by technology, 2018 - 2030 (USD Billion)
  • Table 25 Italy uterine fibroids treatment devices market, by mode of treatment, 2018 - 2030 (USD Billion)
  • Table 26 Spain uterine fibroids treatment devices market, by technology, 2018 - 2030 (USD Billion)
  • Table 27 Spain uterine fibroids treatment devices market, by mode of treatment, 2018 - 2030 (USD Billion)
  • Table 28 Norway uterine fibroids treatment devices market, by technology, 2018 - 2030 (USD Billion)
  • Table 29 Norway uterine fibroids treatment devices market, by mode of treatment, 2018 - 2030 (USD Billion)
  • Table 30 Denmark uterine fibroids treatment devices market, by technology, 2018 - 2030 (USD Billion)
  • Table 31 Denmark uterine fibroids treatment devices market, by mode of treatment, 2018 - 2030 (USD Billion)
  • Table 32 Sweden uterine fibroids treatment devices market, by technology, 2018 - 2030 (USD Billion)
  • Table 33 Sweden uterine fibroids treatment devices market, by mode of treatment, 2018 - 2030 (USD Billion)
  • Table 34 Russia uterine fibroids treatment devices market, by technology, 2018 - 2030 (USD Billion)
  • Table 35 Russia uterine fibroids treatment devices market, by mode of treatment, 2018 - 2030 (USD Billion)
  • Table 36 Asia Pacific uterine fibroids treatment devices market, by country, 2018 - 2030 (USD Billion)
  • Table 37 Asia Pacific uterine fibroids treatment devices market, by technology, 2018 - 2030 (USD Billion)
  • Table 38 Asia Pacific uterine fibroids treatment devices market, by mode of treatment, 2018 - 2030 (USD Billion)
  • Table 39 Japan uterine fibroids treatment devices market, by technology, 2018 - 2030 (USD Billion)
  • Table 40 Japan uterine fibroids treatment devices market, by mode of treatment, 2018 - 2030 (USD Billion)
  • Table 41 China uterine fibroids treatment devices market, by technology, 2018-2030 (USD Billion)
  • Table 42 China uterine fibroids treatment devices market, by mode of treatment, 2018-2030 (USD Billion)
  • Table 43 India uterine fibroids treatment devices market, by technology, 2018 - 2030 (USD Billion)
  • Table 44 India uterine fibroids treatment devices market, by mode of treatment, 2018 - 2030 (USD Billion)
  • Table 45 Australia uterine fibroids treatment devices market, by technology, 2018 - 2030 (USD Billion)
  • Table 46 Australia uterine fibroids treatment devices market, by mode of treatment, 2018 - 2030 (USD Billion)
  • Table 47 South Korea uterine fibroids treatment devices market, by technology, 2018 - 2030 (USD Billion)
  • Table 48 South Korea uterine fibroids treatment devices market, by mode of treatment, 2018 - 2030 (USD Billion)
  • Table 49 Thailand uterine fibroids treatment devices market, by technology, 2018 - 2030 (USD Billion)
  • Table 50 Thailand uterine fibroids treatment devices market, by mode of treatment, 2018 - 2030 (USD Billion)
  • Table 51 Latin America uterine fibroids treatment devices market, by country, 2018 - 2030 (USD Billion)
  • Table 52 Latin America uterine fibroids treatment devices market, by technology, 2018 - 2030 (USD Billion)
  • Table 53 Latin America uterine fibroids treatment devices market, by mode of treatment, 2018 - 2030 (USD Billion)
  • Table 54 Brazil uterine fibroids treatment devices market, by technology, 2018 - 2030 (USD Billion)
  • Table 55 Brazil uterine fibroids treatment devices market, by mode of treatment, 2018 - 2030 (USD Billion)
  • Table 56 Argentina uterine fibroids treatment devices market, by technology, 2018 - 2030 (USD Billion)
  • Table 57 Argentina uterine fibroids treatment devices market, by mode of treatment, 2018 - 2030 (USD Billion)
  • Table 58 Colombia uterine fibroids treatment devices market, by technology, 2018 - 2030 (USD Billion)
  • Table 59 Colombia uterine fibroids treatment devices market, by mode of treatment, 2018 - 2030 (USD Billion)
  • Table 60 Middle East & Africa uterine fibroids treatment devices market, by country, 2018 - 2030 (USD Billion)
  • Table 61 Middle East & Africa uterine fibroids treatment devices market, by technology, 2018 - 2030 (USD Billion)
  • Table 62 Middle East & Africa uterine fibroids treatment devices market, by mode of treatment, 2018 - 2030 (USD Billion)
  • Table 63 South Africa uterine fibroids treatment devices market, by technology, 2018 - 2030 (USD Billion)
  • Table 64 South Africa uterine fibroids treatment devices market, by mode of treatment, 2018 - 2030 (USD Billion)
  • Table 65 Saudi Arabia uterine fibroids treatment devices market, by technology, 2018 - 2030 (USD Billion)
  • Table 66 Saudi Arabia uterine fibroids treatment devices market, by mode of treatment, 2018 - 2030 (USD Billion)
  • Table 67 UAE uterine fibroids treatment devices market, by technology, 2018 - 2030 (USD Billion)
  • Table 68 UAE uterine fibroids treatment devices market, by mode of treatment, 2018 - 2030 (USD Billion)
  • Table 69 Kuwait uterine fibroids treatment devices market, by technology, 2018 - 2030 (USD Billion)
  • Table 70 Kuwait uterine fibroids treatment devices market, by mode of treatment, 2018 - 2030 (USD Billion)

List of Figures

  • Fig. 1 Uterine fibroids treatment devices market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 Market formulation & validation
  • Fig. 8 Market snapshot
  • Fig. 9 Technology outlook (USD Billion)
  • Fig. 10 Mode of treatment outlook (USD Billion)
  • Fig. 11 Competitive landscape
  • Fig. 12 Uterine fibroids treatment devices market dynamics
  • Fig. 13 Uterine fibroids treatment devices market: Porter's five forces analysis
  • Fig. 14 Uterine fibroids treatment devices market: PESTLE analysis
  • Fig. 15 Uterine fibroids treatment devices market: Technology segment dashboard
  • Fig. 16 Uterine fibroids treatment devices market: Technology market share analysis, 2024 & 2030
  • Fig. 17 Surgical techniques market, 2018 - 2030 (USD Billion)
  • Fig. 18 Hysterectomy market, 2018 - 2030 (USD Billion)
  • Fig. 19 Myomectomy market, 2018 - 2030 (USD Billion)
  • Fig. 20 Laparoscopic techniques market, 2018 - 2030 (USD Billion)
  • Fig. 21 Laparoscopic myomectomy market, 2018 - 2030 (USD Billion)
  • Fig. 22 Myolysis market, 2018 - 2030 (USD Billion)
  • Fig. 23 Ablation techniques market, 2018 - 2030 (USD Billion)
  • Fig. 24 Microwave ablation market, 2018 - 2030 (USD Billion)
  • Fig. 25 Hydrothermal ablation market, 2018 - 2030 (USD Billion)
  • Fig. 26 Cryoablation market, 2018 - 2030 (USD Billion)
  • Fig. 27 Ultrasound ablation market, 2018 - 2030 (USD Billion)
  • Fig. 28 High intensity focused ultrasound (HIFU) market, 2018 - 2030 (USD Billion)
  • Fig. 29 MRI-guided focused ultrasound (MRgFUS) market, 2018 - 2030 (USD Billion)
  • Fig. 30 Embolization techniques market, 2018 - 2030 (USD Billion)
  • Fig. 31 Uterine fibroids treatment devices market: Mode of treatment segment dashboard
  • Fig. 32 Uterine fibroids treatment devices market: Mode of treatment market share analysis, 2024 & 2030
  • Fig. 33 Invasive treatment market, 2018 - 2030 (USD Billion)
  • Fig. 34 Minimally invasive treatment market, 2018 - 2030 (USD Billion)
  • Fig. 35 Non-invasive Treatment market, 2018 - 2030 (USD Billion)
  • Fig. 36 Uterine fibroids treatment devices market revenue, by region
  • Fig. 37 Regional marketplace: Key takeaways
  • Fig. 38 North America uterine fibroids treatment devices market, 2018 - 2030 (USD Billion)
  • Fig. 39 U.S. country dynamics
  • Fig. 40 U.S. uterine fibroids treatment devices market, 2018 - 2030 (USD Billion)
  • Fig. 41 Canada country dynamics
  • Fig. 42 Canada uterine fibroids treatment devices market, 2018 - 2030 (USD Billion)
  • Fig. 43 Mexico country dynamics
  • Fig. 44 Mexico uterine fibroids treatment devices market, 2018 - 2030 (USD Billion)
  • Fig. 45 Europe uterine fibroids treatment devices market, 2018 - 2030 (USD Billion)
  • Fig. 46 UK country dynamics
  • Fig. 47 UK uterine fibroids treatment devices market, 2018 - 2030 (USD Billion)
  • Fig. 48 Germany country dynamics
  • Fig. 49 Germany uterine fibroids treatment devices market, 2018 - 2030 (USD Billion)
  • Fig. 50 France country dynamics
  • Fig. 51 France uterine fibroids treatment devices market, 2018 - 2030 (USD Billion)
  • Fig. 52 Italy country dynamics
  • Fig. 53 Italy uterine fibroids treatment devices market, 2018 - 2030 (USD Billion)
  • Fig. 54 Spain country dynamics
  • Fig. 55 Spain uterine fibroids treatment devices market, 2018 - 2030 (USD Billion)
  • Fig. 56 Norway country dynamics
  • Fig. 57 Norway uterine fibroids treatment devices market, 2018 - 2030 (USD Billion)
  • Fig. 58 Denmark country dynamics
  • Fig. 59 Denmark uterine fibroids treatment devices market, 2018 - 2030 (USD Billion
  • Fig. 60 Sweden country dynamics
  • Fig. 61 Sweden uterine fibroids treatment devices market, 2018 - 2030 (USD Billion)
  • Fig. 62 Russia country dynamics
  • Fig. 63 Russia uterine fibroids treatment devices market, 2018 - 2030 (USD Billion)
  • Fig. 64 Asia Pacific uterine fibroids treatment devices market, 2018 - 2030 (USD Billion)
  • Fig. 65 Japan country dynamics
  • Fig. 66 Japan uterine fibroids treatment devices market, 2018 - 2030 (USD Billion)
  • Fig. 67 China country dynamics
  • Fig. 68 China uterine fibroids treatment devices market, 2018 - 2030 (USD Billion)
  • Fig. 69 India country dynamics
  • Fig. 70 India uterine fibroids treatment devices market, 2018 - 2030 (USD Billion)
  • Fig. 71 South Korea country dynamics
  • Fig. 72 South Korea uterine fibroids treatment devices market, 2018 - 2030 (USD Billion)
  • Fig. 73 Australia country dynamics
  • Fig. 74 Australia uterine fibroids treatment devices market, 2018 - 2030 (USD Billion)
  • Fig. 75 Thailand country dynamics
  • Fig. 76 Thailand uterine fibroids treatment devices market, 2018 - 2030 (USD Billion)
  • Fig. 77 Latin America uterine fibroids treatment devices market, 2018 - 2030 (USD Billion)
  • Fig. 78 Brazil country dynamics
  • Fig. 79 Brazil uterine fibroids treatment devices market, 2018 - 2030 (USD Billion)
  • Fig. 80 Argentina country dynamics
  • Fig. 81 Argentina uterine fibroids treatment devices market, 2018 - 2030 (USD Billion)
  • Fig. 82 Colombia country dynamics
  • Fig. 83 Colombia uterine fibroids treatment devices market, 2018 - 2030 (USD Billion)
  • Fig. 84 MEA uterine fibroids treatment devices market, 2018 - 2030 (USD Billion)
  • Fig. 85 South Africa country dynamics
  • Fig. 86 South Africa uterine fibroids treatment devices market, 2018 - 2030 (USD Billion)
  • Fig. 87 Saudi Arabia country dynamics
  • Fig. 88 Saudi Arabia uterine fibroids treatment devices market, 2018 - 2030 (USD Billion)
  • Fig. 89 UAE country dynamics
  • Fig. 90 UAE uterine fibroids treatment devices market, 2018 - 2030 (USD Billion)
  • Fig. 91 Kuwait country dynamics
  • Fig. 92 Kuwait uterine fibroids treatment devices market, 2018 - 2030 (USD Billion)
  • Fig. 93 Company categorization
  • Fig. 94 Company market position analysis
  • Fig. 95 Strategic framework